Veterinary Vaccines Market Growth Factors, Competitive landscape, Emerging Trends and Forecast to 2028
According to our new research study on “Veterinary Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Vaccine Type and Technology,” the market is projected to reach US$ 15,536.38 million in 2028 from US$ 9,984.65 million in 2021; it is estimated to register a CAGR of 6.5% from 2021 to 2028.
The report highlights trends existing in the market, and drivers
and hindrances pertaining to the market growth. The companion animal category
is predicted to increase at the highest rate because of the high frequency with
which these animals come into contact with people and the fact that illnesses
such as rabies can harm humans as well. Additionally, a boost in the adoption
of these companion animals and increased knowledge of the need for dog and cat
vaccinations contribute to the market's growth. Cats and dogs receive companion
animal immunizations. Vaccines for livestock are frequently administered to
farm animals. In 2020, the livestock vaccination market held the largest market
share. The reason for this is that these animals are routinely vaccinated more
frequently than companion animals. Besides, the segment's quick rise has been
attributed to the rapid expansion of companion animal vaccinations,
advancements in diagnostic services and vaccine technology, and worries over
vaccine safety. Additionally, the industry is benefited by improving
immunization regimens in response to changing disease patterns and the pet
population. Thus, the benefits of veterinary vaccines are expected to drive the
segment during the forecast period.
Download
the PDF Sample Here: https://www.theinsightpartners.com/sample/TIPRE00003539/
The global veterinary vaccines market, based on vaccine type, is
segmented into livestock vaccines, companion animal vaccines, and others. The
livestock vaccines segment is likely to hold the largest market share in 2021.
However, the companion animal segment is anticipated to register the highest
CAGR of 7.0% during the forecast period.
The global veterinary vaccines market, based on technology, is
segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines,
recombinant vaccines, conjugate vaccines, and others. In 2021, the live
attenuated vaccines segment is likely to hold the largest market share. However,
the inactivated vaccines segment is expected to grow at the highest CAGR from
2021 to 2028.
Boehringer Ingelheim International GmbH; Zoetis Inc.; Merck & Co., Inc.; Virbac; BIOVAC; NEOGEN Corporation; Elanco; HIPRA; Ceva; and Hester Biosciences Limited are a few leading companies operating in the veterinary vaccines market. The companies adopt inorganic and organic growth strategies to expand their footprints and product portfolio worldwide to meet the rising demands for veterinary vaccines. In July 2021, Boehringer Ingelheim launched FreVAX smartphone app (2.0 version) for the management of FreVAX intramuscular needle-free device.
About Us:
The Insight Partners is a one stop industry research
provider of actionable intelligence. We help our clients in getting solutions
to their research requirements through our syndicated and consulting research
services. We specialize in industries such as Semiconductor and Electronics,
Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare
IT, Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would
like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment